LONDON, March 14, 2011 /PRNewswire/ --
- Major Biologic Approvals Worth $4.5bn in 2015 Omitted From Most FDA
Approval Counts Last Year
- Provenge and Prevnar 13 Overlooked in Majority of 2010 Tallies
- 65 new Biologics Have Largely Gone Uncounted in the Last 12 Years
- Overall